Accrol Group CEO on shareholder returns, more acquisitions and licence agreements (LON:ACRL) 30 November 2023
Diversified Energy: Operational prowess, asset sale and “highly value accretive” share buyback – Peel Hunt’s views (LON:DEC) 30 June 2023
Tirupati Graphite acquisition targets EV-driven “global Graphite overdemand”, Daniel Ingram, Optiva Securities 28 June 2023
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
Accrol Group CEO on shareholder returns, more acquisitions and licence agreements (LON:ACRL) 30 November 2023
Diversified Energy: Operational prowess, asset sale and “highly value accretive” share buyback – Peel Hunt’s views (LON:DEC) 30 June 2023
Tirupati Graphite acquisition targets EV-driven “global Graphite overdemand”, Daniel Ingram, Optiva Securities 28 June 2023
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
Tyra Biosciences, Inc. (TYRA) Stock Analysis: A Promising 43.54% Upside Potential in Biotech Innovation 19 December 2025
Arvinas, Inc. (ARVN): Investor Outlook on a Biotech Innovator with a 10.26% Potential Upside 19 December 2025
Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising Biotech with 36% Potential Upside 19 December 2025
Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a Potential 46.53% Upside for Investors 19 December 2025
Sana Biotechnology, Inc. (SANA) Stock Analysis: A 90% Upside Potential Beckons Investors 19 December 2025
Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring Its 27% Potential Upside Amidst Healthcare Innovations 19 December 2025
Semler Scientific, Inc. (SMLR) Investor Outlook: Unlocking a 283.79% Potential Upside in the Medical Devices Sector 19 December 2025
InMode Ltd. (INMD) Stock Analysis: Navigating the Healthcare Sector with a 14% Potential Upside 19 December 2025
Bioventus Inc. (BVS) Stock Analysis: Unveiling a Near 95% Upside Potential in the Medical Device Sector 19 December 2025
Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a 72% Potential Upside with Strong Buy Ratings 19 December 2025
LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Unpacking the 214.67% Potential Upside in Biotech Vision Solutions 19 December 2025
Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Promising Biotech with 117% Revenue Growth and Strong Buy Ratings 19 December 2025
Arbutus Biopharma (ABUS) Stock Analysis: Exploring a 25.5% Potential Upside in the Biotechnology Sector 19 December 2025
AxoGen, Inc. (AXGN) Stock Analysis: Analysts See 11.81% Upside in Innovative Nerve Repair Solutions 19 December 2025
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 465% Potential Upside in Biotech 19 December 2025
PureTech Health plc (PRTC): A Biotech Contender with Explosive Revenue Growth and Strategic Innovations 19 December 2025
Cross Country Healthcare, Inc. (CCRN): Investor Outlook with a 20.33% Potential Upside 19 December 2025
Zotefoams plc Expanded Nike relationship, exciting trial for Rezorce and record H1 profits (VIDEO) 9 August 2023
Accrol Group CEO on shareholder returns, more acquisitions and licence agreements (LON:ACRL) 30 November 2023
Diversified Energy: Operational prowess, asset sale and “highly value accretive” share buyback – Peel Hunt’s views (LON:DEC) 30 June 2023
Tirupati Graphite acquisition targets EV-driven “global Graphite overdemand”, Daniel Ingram, Optiva Securities 28 June 2023
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
